3 ms·
I think that depends on the theories that one has. Either choice would be based on missing or incomplete data. For example, one could question the potential fo
by giantg2 5y ago
I think that depends on the theories that one has. Either choice would be based on missing or incomplete data.
For example, one could question the potential for autoimmune conditions due to the way the mRNA vaccine works and how the immune system typically targets multiple proteins on the cell. There's no data or studies our there about this longterm possibility or even the incidence of autoimmune antibodies produced by vaccination. This likely isn't a problem for the elderly since it can take years or decades to present/progress, and their value proposition is different than for younger people. It starts to get more questionable as the value proposition changes dramatically in the youngest age groups. The question of vaccinating one's child for covid is certainly a topic with a diverse set of opinions and very little data to perform a thorough longterm cost/benefit analysis.
- Pyramus 5y agoCould you explain what you mean by that? We already know Covid can cause autoimmune issues in some patients, so are you saying the effect you describe is just a subset of these, or different?
- giantg2 5y agoIt's it's that there are known and unknown/suspected risks with both actions. We know that some vaccine recipients develop Graves disease. Some autoimmune diseases take years to develop. So we have risks on both sides, but there's not a lot of information about how common those risks are, especially for longer term effects. So all I'm saying is that the value proposition for an individual is based on the risks associated with vaccination or infection, and that the decision for people in age groups with the lowest known (short term) risks associated with infection have lower known benefits putting more emphasis on the unknown (longer term) risks or benefits. So for someone over 70 with about a 5% IFR, it's easy to say there is more benefit than risk because it's easy to see if a serious side effect is happening at a 5% rate or higher and the time horizon for longterm issues developing is limited by natural lifespan. With the quality of the VAERS data and the much longer time horizon, it's more difficult to discern a benefit for someone with an IFR of .002%. Of course we can't even look at the rates of many of the side effects to compare something other than IFR because the data data quality doesn't allow for that level of sensitivity. Edit: why downvote?
- XorNot 5y agoYou are arguing "we don't know what'll happen with vaccines" as though you do know the long term risks of COVID-19. You do not - you cannot. COVID-19 has not existed for longer then about 1.5 years. Other coronaviruses have, but mRNA vaccine technology is about 15 years old - that's how long it's been in development and studied. Long term effects are in fact, known. But if you were concerned about that, you could take J&J or Astrazeneca, both of which are based on adenovirus vector technology and has existed since the 1980s - the clotting side effect is both rare and treatable. re: Graves disease - [1] is literally a risk of getting COVID-19. You are engaging in some both-sideism FUD and misrepresenting the technology of vaccines while pretending a brand new novel disease is some well-understood thing. [1] https://www.healio.com/news/endocrinology/20210519/covid19-may-trigger-graves-disease-relapse-subacute-thyroiditis https://www.healio.com/news/endocrinology/20210519/covid19-m...
- giantg2 5y agoI think you are misunderstanding what I've been saying. "You are arguing "we don't know what'll happen with vaccines" as though you do know the long term risks of COVID-19." I'm saying that the longterm effects are not known for either. "Other coronaviruses have, but mRNA vaccine technology is about 15 years old - that's how long it's been in development and studied." Do you have some links for this? The mRNA technology was used a little differently in the past from what I saw. Most of the research I saw were attempts to correct genetic issues, not trigger immune responses against the proteins created. Not to mention, the OP article even has the FDA stating that they don't know the longterm effects of vaccination, so it seems my statement is consistent with the expert opinion. "But if you were concerned about that, you could take J&J or Astrazeneca, both of which are based on adenovirus vector technology and has existed since the 1980s - the clotting side effect is both rare and treatable." It's a similar mechanism, right? You're just using a virus to carry the genetic material, which also involves an extra transcription step in the cell (what is theorized as causing mutations in the spike and thus the stroke/clotting issues). Still quite different from the traditional inactive or protein based ones. Have either technologies been used in a wide scale way (1M+ people) on the timeframes you mention? "You are engaging in some both-sideism FUD and misrepresenting the technology of vaccines while pretending a brand new novel disease is some well-understood thing." First off, it's not FUD. I'm not fear mongering. There's no doubt expressed about known things. Sure, there is uncertainty about both sides, but even the experts acknowledge this in a similarly objective way (ie I lack the motive behind FUD). My statements have been objective about how one may be approaching the decision. Where have I misrepresented vaccine technology? I am not saying covid is well known - in fact, your statement contradicts your other statement about "both-sidism FUD" since I can't possibly be claiming it's well understood and simultaneously claim fear, uncertainty, and doubt about it. If you read it, you can see the discussion is about how people might be approaching a decision with a mix of fairly well known short term data and relatively little known long term data, and how the value proposition changes. https://www.euronews.com/next/2021/05/27/why-are-aztrazeneca-and-j-j-vaccines-causing-blood-clots-scientists-claim-they-have-the-an https://www.euronews.com/next/2021/05/27/why-are-aztrazeneca... https://www.europeanpharmaceuticalreview.com/news/155536/breaking-news-researchers-may-know-the-cause-for-covid-19-vaccine-related-blood-clots/ https://www.europeanpharmaceuticalreview.com/news/155536/bre...